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Objective:The purpose of the study is to detect if some parameters can be considered as
predictors of liver regeneration in two different patient populations composed of in living
donors for adult to adult living donor liver transplant and patients with hepatic malignancies
within a single institution.
Summary Background Data: Preoperative multi-detector computed tomography volume-
try is an essential tool to assess the volume of the remnant liver.
Methods: A retrospective analysis from an ongoing clinical study on 100 liver resections,
between 2004 and 2010. Seventy patients were right lobe living donors for liver transplan-
tation and 30 patients were resected for treatment of tumors. Pre-surgical factors such
as age, weight, height, body mass index (BMI), original liver volume, future remnant liver
volume (FRLV), spleen volume, liver function tests, creatinine, platelet count, steatosis,
portal vein embolization, and number of resected segments were analyzed to evidence
potential markers for liver regeneration.
Results: Follow-up period did not influence the amount of liver regenerated: the linear
regression evidenced that there is no correlation between percentage of liver regenera-
tion and time of follow-up (p=0.88). The pre-surgical variables that resulted markers of
liver regeneration include higher preoperative values of BMI (p=0.01), bilirubin (p=0.04),
glucose (p=0.05), and gamma-glutamyl transpeptidase (p=0.014); the most important
association was revealed regarding the lower FRLV (p<0.0001) and percentage of liver
regeneration. The stepwise regression revealed a strong impact of FRLV (p<0.0001) on
the other predictor variables.
Conclusion: Liver regeneration follows similar pathway in living donor and in patients
resected for cancer. Small FRLV tends to regenerate more and faster, confirming that a
larger resections may lead to a greater promotion of liver regeneration in patients with
optimal conditions in terms of body habitus, preoperative liver function tests, and glucose
level.
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INTRODUCTION
The main troubleshooting for a successful hepatic resection is
closed related to the regenerative properties of the liver in response
to a greater tissue excision after resective surgical therapies for pri-
mary or secondary tumors of the liver and after living donor liver
transplantation. The human liver is able to regenerate due to a
hyperplastic reaction in the remnant liver (1). However, a “small-
for-size” syndrome can occur when the excised liver parenchyma
is mayor of the 80% of the total liver volume and the hepatic
function does not sustain physiologic needs (2). Preoperative
multi-detector computed tomography (MDCT) volumetry is an
essential tool to assess the volume of the liver remnant for surgi-
cal success (3–8). An increased interest in the outcomes of major
hepatectomy for adult to adult living related liver transplanta-
tion (LRLT) has likely contributed to these breakthroughs. Clearly,
LRLT represents the natural evolution of other surgical proce-
dures, namely reduced-size liver transplantation and split liver
transplantation (4), and is based on the segmental anatomy of
the liver and on its peculiar capacity to regenerate. LRLT was ini-
tially performed successfully in the pediatric population (5), and
then proposed as one of the most effective measures to counter-
act organ shortage in adults (9–12). However, although surgical
techniques of excellence and major improvements in perioper-
ative management are now a reality in referral centers for liver
surgery, there are still several issues that make this major surgi-
cal procedure extremely worrisome, especially when considering
the tragic sequels of post-resection liver failure (13). Although
appropriate liver remnant volume after resection ensures the liver’s
ability to regenerate, regeneration progresses at variable rates in
patients. Preoperative and postoperative MDCT scans have been
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used as a means to study the effects of perioperative factors such
as splanchnic hemodynamics and middle hepatic vein harvesting
on liver regeneration (10–12). Nevertheless, few papers have stud-
ied pre-surgical clinical and biochemical factors that may influence
liver regeneration rate. Some studies show that pre-surgical factors
such as age, gender, body mass index (BMI), native liver disease,
chemotherapy, platelet count, and steatosis might influence liver
regeneration (2, 14–17). The aims of this study were to compare
liver regeneration after liver resection in living donors for LRLT
and patients with malignancies within a single institution and
determine if pre-surgical factors such as age, weight, height, BMI,
original liver volume, FRL, spleen volume, liver function tests, cre-
atinine, platelet count, steatosis, portal vein embolization (PVE),
and number of segments resected have a significant predictive
value for liver regeneration.
MATERIALS AND METHODS
STUDY POPULATION
Our study was approved by the “Istituto Mediterraneo per i Trapi-
anti e Terapie ad Alta Specializzazione” (Is.Me.T.T.) Institutional
Research Review Board and patients were selected retrospectively
from an ongoing clinical study on liver resection. Between Novem-
ber 2004 and January 2010, all patients without chronic liver
disease who underwent liver resection of at least two segments,
according to the Couinaud classification (18) with pre- and post-
operative abdominal MDCT scans were included. A total of 100
patients were identified with 70 patients who were right lobe liv-
ing donors for LRLT (Group A) and 30 patients who had resection
for treatment of hepatic tumors (Group B). Living donor patients
were the control in our study since their liver must be immaculate
for transplantation.
As described and published elsewhere, we adopted validated
methods for MDCT technique and for volumetric estimations of
the liver and the spleen (9).
EVALUATION OF PRE-SURGICAL FACTORS
Blood biochemical tests were performed prior to operation in
all 100 patients. Values drawn from electronic medical records
include: alanine aminotransferase (ALT), aspartate aminotrans-
ferase (AST), albumin, total bilirubin, gamma-glutamyl transpep-
tidase (GGT), glucose, platelet count, and PT/INR. Steatosis was
measured using the Hounsfield units of the liver from a basal CT
scan and using the spleen Hounsfield unit as a reference value.
Portal hypertension was measured indirectly by measuring the
diameter of the common portal vein on portal venous phase
images. We also noted the number of Couinaud segments removed
and previous PVE from patients with tumors.
TYPE OF LIVER RESECTION IN PATIENTS WITH LIVER MALIGNANCIES
Couinaud classification was used for defining major liver resec-
tions with the excision of three or more liver segments and
included Right or Left Hepatectomies, Extended or not. The right
hemiliver was removed in all of the patients in Group A, Couin-
aud segments 5–8. The technical breakthroughs and surgical skills
developed in the LRLT were used even for patients with liver tumor.
Group B consisted of 15 patients with primary neoplasm (hepato-
cellular carcinoma in 5 cases, 7 cases of intrahepatic cholangiocar-
cinoma, in 1 case hilar cholangiocarcinoma, in 1 case gallbladder
cancer, and in 1 case huge hepatobiliary cystadenoma), and the 15
remnant with liver metastases (from ileal neuroendocrine tumor
in 1 case, from ovarian leiomyosarcoma in 1 case, from gastroin-
testinal stromal tumor in 1 case, and in 12 cases from colorectal
cancer).
LIVING RELATED LIVER DONATION
As previously described elsewhere, living donor safety has to be the
first priority during the entire process of LRLT, from the first day
of evaluation through the entire follow-up period (9, 19). In our
center a step-by-step work-up protocol for donor evaluation has
been designed and scientifically accepted and published in 2007
for ensuring donor safety and, additionally, for confirming that
the donor is capable of providing a suitable graft for the recipi-
ent (20). “All donors went through a complete evaluation process,
managed by a multidisciplinary team consisting of clinical psy-
chologists, hepatologists, anesthesiologists, transplant surgeons,
referring physicians, and family doctors. The evaluation process
was completed in 3 days, with blood work, ultrasound, and con-
sults on the first day; Volumetric Angio Computed Tomography
scan and Cholangio Nuclear Magnetic Resonance Imaging (MRI)
on the second day; and liver biopsy on the third day. The opera-
tion was performed with a bilateral subcostal incision, with upper
midline extension (Mercedes incision). Mobilization of the right
liver and skeletonization of the retro-hepatic inferior vena cava
with ligation of all accessory hepatic veins was performed using
the usual piggy-back technique, the only difference consisting in
the preservation of accessory veins larger than 0.8 cm in diam-
eter. Intraoperative cholangiogram was always performed, as was
intraoperative ultrasound, to confirm the transection plane, which
follows the Cantlie line with no vascular occlusion. Isolation of the
right hepatic artery was always performed, while isolation of the
right portal vein was performed prior to the parenchymal transec-
tion only when feasible. The middle hepatic vein always remained
with the donor. The following four sequential techniques were per-
formed for the hepatic parenchymal transection: (1) parenchyma
tissue fragmentation and skeletonization of biliary-vascular struc-
tures with the ultrasonic dissector or water pressure dissector; (2)
vascular hemostasis and biliostasis of the minuscule biliary ducts
through the use of micro surgical clips and the radiofrequency dis-
sector; (3) section of fibrous and vascular-biliary structures with
electrocautery; and (4) suction of organic and irrigation fluids
mixed with parenchymal detritus using the aspirator and the inte-
grated aspirator in the ultrasonic dissector. The setting of the ultra-
sonic dissector was 90% in amplitude, with high tissue selection,
while the irrigation rate was 5 ml/h, with suction set at maximum
strength. This was applied after the liver capsule was opened by
diathermy, set on coagulation at 70 W. The radiofrequency setting
was 75 W, and the irrigation rate was between 2.5 and 5 ml/h. The
division of the biliary duct was performed just before the end of
the parenchymal transection, and always sharply” (20).
STATISTICAL ANALYSES
All statistical analyses were performed by using the IBM SPSS Sta-
tistics 18 (SPSS Inc., Chicago, IL, USA). Group data were expressed
as mean± SD. Regeneration percentages and pre-surgical factors
were compared between living liver donor patients and patients
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with tumors using the Student’s two-sample t -test or the Wilcoxon
Rank-Sum test with α= 0.05. The effects of the number of Couin-
aud segments, PVE, and type of liver disease on percentage of
regeneration were analyzed in patients with neoplasms using two-
sample t -tests. A percentile analysis of percent of regeneration
was performed for all patients. Pre-surgical factors were compared
between living liver donor patients and patients with malignancies
using the Student’s two-sample t -test or the Wilcoxon Rank-Sum
test with α= 0.05. A multiple regression analysis was performed at
least to compare the regeneration parenchymal rate to the future
remnant liver volume (FRLV): the regression coefficient of each
any analyzed factor was defined as the partial regression coefficient
because it represents the contribution to the response comparison
after it has been adjusted for the other predictor variables.
RESULTS
LIVING LIVER DONORS (GROUP A) vs. PATIENTS WITH LIVER TUMORS
(GROUP B)
Patient characteristics and pre-surgical factors were different
between the two groups of cases except for weight, serum bilirubin
level, percentage of prothrombin time, and diameter of portal vein.
Factors that show significant difference between groups (p< 0.05)
included: height, BMI, original liver volume, ALT, albumin, AST,
creatinine, GGT, platelet, INR, steatosis, spleen volume, and glu-
cose (Table 1). Our study shows that the significant differences in
the mean value of some pre-surgical factors examined in this study
between the two groups induced a wide variety of distribution of
percent liver regeneration. However, the percent regeneration rate
did not differ (Wilcoxon Rank-Sum test, p= 0.357) between the
two groups, being in Group B, 86.38± 56.91 (95% Confidence
Interval, CI: 64.12, 108.64), and in Group A, 94.68± 37.52 (95%
CI: 85.73, 103. 62).
PATIENTS WITH LIVER TUMORS (GROUP B)
Analyzing Group B, the plot of percent liver regeneration vs. time
of follow-up did not evidence a clear influence with an uni-
variable regression coefficient of −0.040 and a p-value of 0.877
(r-squared= 0.0009, 95% CI: −0.559, 0.480). Nevertheless, in
accord to the number of Couinaud segments resected, we recorded
16 cases who underwent to more/equal five segments resection
with an average 112.403± 57.859 percentage of liver parenchy-
mal regeneration (95% CI: 81.572, 143.233), in contrast with the
remnant 14 patients, 56.643± 47.726 (95% CI: 85.73, 103. 62).
Clearly, the two-sample t -test comparison of the percentage regen-
eration by number of segments resected evidenced that who had
more than five segments resected showed greater liver regenera-
tion (p= 0.008) (Figure 1A). In this settings, we compared the
percentages of liver regeneration in eight patients affected by liver
malignancies who underwent PVE (105.993± 49.922, 95% CI:
64.257, 147.728) with the remnant 22 (79.250± 62.259, 95% CI:
Table 1 | Demographic characteristics for all patients and comparison of pre-surgical factors between patient types: living liver donors and
patients with liver malignancies.
Pre-surgical factor Living liver donors (n=70) Patients with liver malignancies (n=30) Overall cases (n=100) p-Value
Mean±SD Mean±SD Mean±SD
Age (years) 32.38 ± 9.05 58.70 ± 14.06 40.28 ± 16.19 0.000a
Weight (kg) 69.44 ± 11.18 72.17 ± 12.63 70.26 ± 11.64 0.29
Height (cm) 170.54 ± 8.83 166 ± 9.27 169.18 ± 9.16 0.022a
BMI 23.80 ± 2.95 26.16 ± 3.87 24.51 ± 3.42 0.001a
Original liver volume (cc) 1571.5 ± 278.71 2013.08 ± 766.36 1703.98 ± 517.25 0.002a,b
Future remnant liver (cc) 584.3 ± 105.18 677.19 ± 333.78 612.17 ± 205.37 0.636b
Bilirubin (mg/dl) 0.69 ± 0.38 0.92 ± 1.83 0.76 ± 1.02 0.521
ALT (U/l) 42.50 ± 11.28 60.33 ± 32.52 47.46 ± 21.03 0.010a,b
Albumin (g/dl) 4.25 ± 0.38 3.28 ± 0.73 3.98 ± 0.67 0.000a,b
AST (U/l) 21.01 ± 6.25 77.07 ± 144.12 29.37 ± 2.74 0.000a,b
Creatinine (mg/dl) 0.812 ± 0.18 0.925 ± 0.24 0.844 ± 0.21 0.016a
GGT (U/l) 27.87 ± 12.28 181.71 ± 161.73 72.27 ± 111.24 0.000a,b
Platelet (103/µl) 222.47 ± 46.55 271.39 ± 104.47 236.44 ± 71.22 0.033a,b
Prothrombin time (%) 101.87 ± 18.15 93.76 ± 22.04 99.55 ± 19.57 0.064
PT/INR 0.97 ± 0.10 1.07 ± 0.16 1.00 ± 0.13 0.005a
Steatosis (Hounsfeld units) 1.17 ± 0.14 1.09 ± 0.17 1.15 ± 0.15 0.023a
Portal vein diameter (mm) 12.91 ± 2.22 13.44 ± 2.33 13.08 ± 2.25 0.288
Spleen volume (cc) 260.04 ± 125.57 307.69 ± 125.57 274.74 ± 109.41 0.003a,b
Glucose (mg/dl) 97.1 ± 2.9 75.01 ± 25 88.01 ± 9.01 0.002a,c
aStatistically significant.
bWilcoxon Rank-Sum test.
cFisher Exact test.
All others are t-tests.
SD, standard deviation.
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FIGURE 1 | Box plots of percentage of liver regeneration by number of
segments resected (A) and based on type of liver malignancy (B).
51.646, 106.854), showing no significant difference (p= 0.285).
The 15 patients resected for primary liver malignancy evidenced an
average of 69.696± 10.736 percentage of liver regeneration (95%
CI: 46.668, 92.724) (Figure 1B), and when compared with the
other 15 operated for liver metastases (103.066± 18.319, 95% CI:
63.773,142.358),no significant difference was detected (p= 0.063)
(Figure 2A).
LIVER REGENERATION OVER/UNDER TWENTIETH PERCENTILE
ANALYSIS
Patients under the twentieth percentile regenerated 50% or less.
This was used as a cut-off to separate all 100 patients into other two
different groups: optimal regeneration and sub-optimal regener-
ation (Table 2). Percentile analysis showed that patients above
the twentieth percentile regenerated approximately 50% or more
according to the FRLV. A significant differences in the mean value
of some pre-surgical factors was examined between patients above
the twentieth percentile for percent liver regeneration (n= 21)
and patients below the twentieth percentile for liver regenera-
tion (n= 79). Factors that showed significant difference between
groups include: BMI, FRLV, GGT, and serum levels of bilirubin and
glucose (t -test and Wilcoxon Rank-Sum test, p< 0.05). (Table 3)
The two-sample t -test and Wilcoxon Rank-Sum (Mann–Whitney)
test of the average FRL for all of the cases under the twentieth per-
centile (887.754± 260.09; 95% CI: 769.35, 1006.14) and for all
FIGURE 2 | Percentage distribution of liver regeneration rate in cases
of control group and in patient with liver malignancies (A). Scatter plot
percentage of liver regeneration compared with future remnant liver
volume (B).
Table 2 | Descriptive percentile distribution of percentage liver
regeneration for all patients.
Percentile Centile (% liver regeneration) 95% Confidence interval
10 31.26 (18.87, 45.04)
20 52.32 (37.04, 68.26)
30 72.32 (53.75, 79.71)
40 80.07 (72.96, 91.74)
50 91.77 (80.20, 99.53)
60 99.58 (91.80, 110.98)
70 111.98 (100.89, 125.43)
80 126.16 (113.65, 136.22)
90 142.64 (130.62, 185.81)
100 219.96 (219.96, 219.96)
of the cases over the above percentile cut-off (538.910± 101.51;
95% CI: 516.17, 561.64) showed a significant inverse correlation
between the percent liver regeneration and FRLV for all patients
(p< 0.0001) (Figure 2B).
MULTIPLE REGRESSION ANALYSIS
The analysis included the following predictor variables of liver
regeneration: FRLV, BMI, GGT, time of follow-up, spleen volume,
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Table 3 | Comparison of risk factors between patients above (n=21) and below the twentieth percentile (n=79) for and liver regeneration.
Pre-surgical factors Under twentieth percentile Over twentieth percentile p-Value
Mean±SD Mean±SD
Age (years) 48.33 ± 21.07 38.13 ± 14.01 0.074b
Weight (kg) 72.19 ± 11.51 69.74 ± 11.69 0.394
Height (cm) 165.85 ± 9.35 170.06 ± 8.96 0.061
Body mass index 26.21 ± 3.18 24.06 ± 3.35 0.009a
Original liver volume (cc) 1793.19 ± 467.64 1680.25 ± 529.89 0.377
Future remnant liver volume (cc) 887.75 ± 260.09 538.91 ± 101.51 0.000a,b
Bilirubin (mg/dl) 0.96 ± 2.15 0.71 ± 0.41 0.039a,b
ALT (U/l) 52.3 ± 30.21 51.89 ± 53.32 0.650b
Albumin (g/dl) 3.72 ± 0.67 4.04 ± 0.66 0.059
AST (U/l) 29.4 ± 17.47 38.97 ± 89.67 0.074
Creatinine (mg/dl) 0.83 ± 0.24 0.84 ± 0.20 0.729
GGT (U/l) 125.45 ± 179.44 58.46 ± 81.50 0.014a
Platelet (103/µl) 241.75 ± 59.82 235.08 ± 74.15 0.711
Prothrombin time (%) 101.68 ± 20.58 99.01 ± 19.57 0.588
PT/INR 0.98 ± 0.12 1.01 ± 0.13 0.599
Steatosis (Hounsfield units) 1.11 ± 0.19 1.16 ± 0.14 0.146
Portal vein diameter (cm) 12.68 ± 2.04 13.19 ± 2.31 0.363
Original spleen volume (cc) 246.53 ± 63.85 282.85 ± 118.45 0.411
Glucose (mg/dl) 104.6 ± 33.60 94.19 ± 22.93 0.046b
aStatistically significant.
bWilcoxon Rank-Sum test.
All others are t-tests.
albumin levels, steatotic grade, and the number of resected seg-
ments, age, and membership in the Group B vs. Group A. The
partial regression coefficients evidenced with the stepwise regres-
sion revealed a significant association between liver regenera-
tion and FRLV (p< 0.0001), BMI (p< 0.0001), time of follow-
up (p< 0.0001), spleen volume (p< 0.0001), age (p= 0.033),
and albumin levels (p= 0.038). A unit change in one of
these predictive factors, when all other are held constant, con-
tributed to strongly modify the liver regeneration after resec-
tion. The magnitude of the change was not dependent on
the values at which the other predictor variables were held
(Table 4).
DISCUSSION
Liver resection success relies on the remnant liver’s ability to regen-
erate. The human liver is able to regenerate due to a hyperplastic
reaction in the residual liver (1). Some studies suggest that pre-
surgical factors such as age, gender, BMI, native liver disease,
chemotherapy, platelet count, and steatosis might have a sig-
nificant influence on human liver regeneration (2, 14–17). One
study in particular demonstrates that an elevated platelet counts
in mice after 90% hepatectomy is beneficial for liver regenera-
tion (21). Having seen such correlations in pre clinical setting,
we wanted to identify pre-surgical factors as potential marker of
liver regeneration in right lobe living donors for living related liver
transplant and in patients with liver tumors. There was no statis-
tically significant difference in percent liver regeneration between
the two groups, as similarly reported in the study by Zappa et al.
regarding the effects on middle hepatic vein harvesting during
Table 4 | Multiple regression analysis performed to compare the
regeneration parenchymal rate to the future remnant liver volume:
the stepwise regression coefficient represents the contribution to the
response comparison after it has been adjusted for other predictor
variables.
Pre-surgical factors Coefficient p-Value 95% Confidence
interval
Future remnant liver volume −0.15 <0.0001 (−0.19, −0.11)
Body mass index 4.06 <0.0001 (1.95, 6.18)
Albumin −12.8 0.038 (−23.5, −0.67)
Spleen volume 57.7 <0.0001 (29.05, 86.51)
Time of follow-up 0.54 <0.0001 (0.29, 0.79)
Age −0.54 0.033 (−1.04, −0.04)
liver resection on liver regeneration (12). This finding gave us
the opportunity to associate the two patient populations together
and perform an over/under twentieth percentile analysis for all
100 patients. Looking at patients resected for liver tumors, our
study found no correlation between percent liver regeneration
and time of follow-up. This suggests that the time after resection
alone does not dictate percent liver regeneration and that other
factors are at work. Stratification of patients with liver neoplasm
by number of Couinaud segments resected showed that patients
with five or more Couinaud segments resected had significantly
greater percent liver regeneration. Olthoff mentions multiple stud-
ies showing the release of pro-inflammatory cytokines such as
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tumor necrosis factor alpha and interleukin-6 after injury due to
resection to initiate the regenerative process (14). Resection of
a larger portion of the liver may lead to the release of a greater
concentration of these cytokines and promote growth (22, 23).
Regarding PVE, although most studies showed significant FRLV
growth after this procedure (24–26), in our series there was no
significant difference in liver regeneration rate after liver resec-
tion when comparing patients who had pre-operative PVE with
those who did not. In addition, our analysis also suggests that
the type of malignancy, primary vs. metastasis, may have not an
effect on liver regeneration in resected patients. The under/over
twentieth percentile analysis was performed in all 100 patients
since there was no significant difference in percent liver regenera-
tion between Group A and B. The twentieth percentile for percent
liver regeneration was used as a cut-off since patients below this
value evidenced a percentage of hepatic regeneration inferior of
52.32%, which was considered sub-optimal. There were signif-
icant differences in values for the following variables between
patients below and above the twentieth percentile: BMI, FRLV,
bilirubin, glucose, and GGT. Each of these variables was signifi-
cantly greater in patients who were below the twentieth percentile
for liver regeneration. Our single center study showed that liver
regeneration follows similar pathways in living donor of right
lobe for living related or unrelated liver transplantation and in
patients resected for liver tumors. Finally, the multiple regression
analysis was performed on the correlation between percent liver
regeneration and FRLV. There is a significant inverse correlation
between percent liver regeneration and FLRV. Larger resections
may lead to a greater concentration of cytokines and promote
growth. However, the key point is to identify the lower limit of
FRLV in order to avoid “small-for-size” syndrome and related
complications (2, 26, 27).
The most important bias of this study is that the Group B is
small and appears to be heterogeneous regarding underlying dis-
ease. And for this reason the statistical sub-analysis could be not
meaningful due to small study sample size. Otherwise, it should be
a primer study for detecting liver regeneration predictors that will
be used for other potential comparison between cases with healthy
liver parenchyma and patients with liver cirrhosis and portal
hypertension. To the best of our knowledge, for the first time in the
literature we might observe that for every 100 cc of FRLV in reduc-
tion we predicted an average regeneration increase of about 15%.
It is the percentage that was adjusted for all other predictors such
as BMI, age, time of follow-up, spleen volume, and albumin levels.
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